Katherine Andersen Overview

  • Primary Position
  • Head of Life Sci...

  • Primary Industry
  • Healthcare

  • Med. Deal Size

Katherine Andersen General Information

Biography

Ms. Katherine Andersen served as Head of Life Science and Healthcare, at HSBC USA Commercial Banking at HSBC Holdings. She served as Head of US Life Science & Healthcare at Silicon Valley Bank. She also sits on the Board of Directors for SVB's Joint Venture in China, SPD Silicon Valley Bank. Before SVB, she was a senior vice president for Wells Fargo Bank leading the life sciences business development and relationship management efforts in the Northeast. Before that, she was a director at Wells Fargo Capital Finance focused on front-end business development and underwriting structured loans across various industries. Before Wells, she held various positions across mergers and acquisitions, finance, equity derivatives, audit, and management while at Affiliated Managers Group, Merrill Lynch, GE Corporate Audit Staff, and GE Capital. She has also completed Dartmouth's Tuck Executive Leadership and Strategic Impact Program, Wells Fargo's Transformational Leadership Program, the Program on Negotiation at Harvard Law School, and the GE Capital Financial Management Program. Away from work

Contact Information

Primary Position
Head of Life Science and Healthcare, HSBC USA Commercial Banking, HSBC Holdings
Education
Virginia Polytechnic Institute and State University (Virginia Tech), Bachelor's
Gender
Female
Phone
+44 020
Address
  • 8 Canada Square
  • London E14 5HQ
  • England, United Kingdom
+44 020

Katherine Andersen Positions (1)

Firm name Firm type Title Location Industry Since
HSBC Holdings Company Head of Life Science and Healthcare, HSBC USA Commercial Banking London, United Kingdom International Banks

Katherine Andersen Lead Partner on Deals (3)

Katherine Andersen has been the lead partner on 3 deals. Their latest deal was with Shanghai Innovation Bank, a national banks company. The deal was made for on 30-Sep-2021.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Shanghai Innovation Bank 30-Sep-2021 Corporate Completed National Banks Shanghai, China
Vericel 01-Sep-2016 Completed Biotechnology Cambridge, MA
Ocata Therapeutics 19-Aug-2015 Completed Biotechnology Marlborough, MA

Katherine Andersen Network (38)

Board Members (1)

Name Company Representing Location From
Shanghai Innovation Bank Shanghai Innovation Bank Shanghai, China

Portfolio Executives (37)

Name Company Role Deal date Location
Sophie Xia Shanghai Innovation Bank Managing Director & Head of Marketing and PR 30-Sep-2021 Shanghai, China
Cheng Ying Shanghai Innovation Bank Deputy President & Chief Risk Control Officer 30-Sep-2021 Shanghai, China
Shanghai Innovation Bank Deputy President & Chief Compliance Officer 30-Sep-2021 Shanghai, China
Shanghai Innovation Bank Deputy President & Chief Financial Officer 30-Sep-2021 Shanghai, China
Shanghai Innovation Bank Managing Director & Head of Corporate Banking 30-Sep-2021 Shanghai, China

Katherine Andersen FAQs

  • Who is Katherine Andersen?

    Ms. Katherine Andersen served as Head of Life Science and Healthcare, at HSBC USA Commercial Banking at HSBC Holdings.

  • How much does Katherine Andersen typically invest?

    Katherine Andersen's median deal size is .

  • What is Katherine Andersen’s main position?

    Katherine Andersen’s primary position is Head of Life Science and Healthcare, HSBC USA Commercial Banking.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »